WikiDrug / Drug classes

Drug Classes

Explore medicines grouped by their pharmacological properties and mechanisms.

5-alpha-reductase-inhibitors

Medicines that inhibit conversion of testosterone to dihydrotestosterone.

0 linked medicines

5-alpha-reductase-inhibitors

Medicines that inhibit conversion of testosterone to dihydrotestosterone.

0 linked medicines

5-ht3-antagonists

Antiemetics that block serotonin 5-HT3 receptors.

0 linked medicines

5-ht3-antagonists

Antiemetics that block serotonin 5-HT3 receptors.

0 linked medicines

ace-inhibitors

Medicines that inhibit angiotensin-converting enzyme and are used in cardiovascular care.

0 linked medicines

ace-inhibitors

Medicines that inhibit angiotensin-converting enzyme and are used in cardiovascular care.

0 linked medicines

acetaminophen-class

Medicines used to relieve pain and reduce fever.

0 linked medicines

acetaminophen-class

Medicines used to relieve pain and reduce fever.

0 linked medicines

alpha-blockers

Medicines that block alpha-adrenergic receptors.

0 linked medicines

alpha-blockers

Medicines that block alpha-adrenergic receptors.

0 linked medicines

aminoglycosides

Antibiotics that inhibit bacterial protein synthesis.

0 linked medicines

aminoglycosides

Antibiotics that inhibit bacterial protein synthesis.

0 linked medicines

angiotensin-ii-receptor-blockers

Medicines that block angiotensin II receptors.

0 linked medicines

angiotensin-ii-receptor-blockers

Medicines that block angiotensin II receptors.

0 linked medicines

anticholinergics

Medicines that block acetylcholine at muscarinic and/or nicotinic receptors.

0 linked medicines

anticholinergics

Medicines that block acetylcholine at muscarinic and/or nicotinic receptors.

0 linked medicines

anticonvulsants

Medicines used to prevent or control seizures.

0 linked medicines

anticonvulsants

Medicines used to prevent or control seizures.

0 linked medicines

antifolate-agents

Medicines that interfere with folate-dependent pathways.

0 linked medicines

antifolate-agents

Medicines that interfere with folate-dependent pathways.

0 linked medicines

antifungals-azoles

Antifungal medicines that inhibit fungal ergosterol synthesis.

0 linked medicines

antifungals-azoles

Antifungal medicines that inhibit fungal ergosterol synthesis.

0 linked medicines

antihistamines-h1

Medicines that block H1 histamine receptors.

0 linked medicines

antihistamines-h1

Medicines that block H1 histamine receptors.

0 linked medicines

antimigraine-triptans

Acute migraine medicines that activate selected serotonin receptors.

0 linked medicines

antimigraine-triptans

Acute migraine medicines that activate selected serotonin receptors.

0 linked medicines

antineoplastic-antimetabolites

Cancer medicines that interfere with nucleotide synthesis or use.

0 linked medicines

antineoplastic-antimetabolites

Cancer medicines that interfere with nucleotide synthesis or use.

0 linked medicines

antiplatelet-agents

Medicines that reduce platelet activation or aggregation.

0 linked medicines

antiplatelet-agents

Medicines that reduce platelet activation or aggregation.

0 linked medicines

antiplatelet-p2y12-inhibitors

Antiplatelet medicines that block the platelet P2Y12 receptor.

0 linked medicines

antiplatelet-p2y12-inhibitors

Antiplatelet medicines that block the platelet P2Y12 receptor.

0 linked medicines

antipsychotics-first-generation

Antipsychotic medicines, many of which primarily block dopamine D2 receptors.

0 linked medicines

antipsychotics-first-generation

Antipsychotic medicines, many of which primarily block dopamine D2 receptors.

0 linked medicines

antipsychotics-second-generation

Antipsychotic medicines with varied dopamine and serotonin receptor activity.

0 linked medicines

antipsychotics-second-generation

Antipsychotic medicines with varied dopamine and serotonin receptor activity.

0 linked medicines

antivirals

Medicines that inhibit viral replication or other stages of viral infection.

0 linked medicines

antivirals

Medicines that inhibit viral replication or other stages of viral infection.

0 linked medicines

aromatase-inhibitors

Medicines that reduce estrogen synthesis.

0 linked medicines

aromatase-inhibitors

Medicines that reduce estrogen synthesis.

0 linked medicines

benzodiazepines

Positive allosteric modulators of GABA-A receptors.

0 linked medicines

beta-blockers

Medicines that block beta-adrenergic receptors.

0 linked medicines

beta-blockers

Medicines that block beta-adrenergic receptors.

0 linked medicines

beta2-agonists

Bronchodilators that stimulate beta-2 adrenergic receptors.

0 linked medicines

beta2-agonists

Bronchodilators that stimulate beta-2 adrenergic receptors.

0 linked medicines

biguanides

Insulin-sensitizing antihyperglycemic medicines.

0 linked medicines

bisphosphonates

Medicines that inhibit bone resorption.

0 linked medicines

calcium-channel-blockers

Medicines that reduce calcium entry into vascular smooth muscle and/or cardiac cells.

0 linked medicines

calcium-channel-blockers

Medicines that reduce calcium entry into vascular smooth muscle and/or cardiac cells.

0 linked medicines

cephalosporins

Beta-lactam antibiotics grouped by cephalosporin generation and structure.

0 linked medicines

cephalosporins

Beta-lactam antibiotics grouped by cephalosporin generation and structure.

0 linked medicines

corticosteroids

Steroid medicines with glucocorticoid and/or mineralocorticoid activity.

0 linked medicines

direct-oral-anticoagulants

Oral medicines that directly inhibit coagulation factors.

0 linked medicines

direct-oral-anticoagulants

Oral medicines that directly inhibit coagulation factors.

0 linked medicines

dmards

Medicines that modify inflammatory or immune pathways in rheumatic disease.

0 linked medicines

dmards

Medicines that modify inflammatory or immune pathways in rheumatic disease.

0 linked medicines

dopamine-agonists

Medicines that activate dopamine receptors.

0 linked medicines

dopamine-agonists

Medicines that activate dopamine receptors.

0 linked medicines

dpp-4-inhibitors

Medicines that prolong incretin activity.

0 linked medicines

dpp-4-inhibitors

Medicines that prolong incretin activity.

0 linked medicines

epoetins

Medicines that stimulate red blood cell production.

0 linked medicines

epoetins

Medicines that stimulate red blood cell production.

0 linked medicines

factor-xa-inhibitors

Anticoagulants that inhibit coagulation factor Xa.

0 linked medicines

factor-xa-inhibitors

Anticoagulants that inhibit coagulation factor Xa.

0 linked medicines

fibrates

Lipid-modifying medicines that primarily affect triglycerides.

0 linked medicines

fibrates

Lipid-modifying medicines that primarily affect triglycerides.

0 linked medicines

fluoroquinolones

Antibiotics that inhibit bacterial DNA gyrase and topoisomerase IV.

0 linked medicines

fluoroquinolones

Antibiotics that inhibit bacterial DNA gyrase and topoisomerase IV.

0 linked medicines

general-anesthetics

Medicines used to produce general anesthesia.

0 linked medicines

general-anesthetics

Medicines used to produce general anesthesia.

0 linked medicines

glp-1-receptor-agonists

Incretin-based medicines used in type 2 diabetes and, for some products, weight management.

0 linked medicines

glp-1-receptor-agonists

Incretin-based medicines used in type 2 diabetes and, for some products, weight management.

0 linked medicines

h2-receptor-antagonists

Medicines that reduce gastric acid secretion through H2 receptor blockade.

0 linked medicines

h2-receptor-antagonists

Medicines that reduce gastric acid secretion through H2 receptor blockade.

0 linked medicines

immune-checkpoint-inhibitors

Cancer immunotherapies that block inhibitory immune checkpoint pathways.

0 linked medicines

immune-checkpoint-inhibitors

Cancer immunotherapies that block inhibitory immune checkpoint pathways.

0 linked medicines

immunosuppressants

Medicines that reduce immune system activity.

0 linked medicines

immunosuppressants

Medicines that reduce immune system activity.

0 linked medicines

inhaled-corticosteroids

Anti-inflammatory medicines delivered by inhalation for airway disease.

0 linked medicines

inhaled-corticosteroids

Anti-inflammatory medicines delivered by inhalation for airway disease.

0 linked medicines

insulins

Hormone replacement medicines used to manage blood glucose.

0 linked medicines

iron-replacement

Medicines and products used to treat or prevent iron deficiency.

0 linked medicines

iron-replacement

Medicines and products used to treat or prevent iron deficiency.

0 linked medicines

laxatives

Medicines that promote bowel movements.

0 linked medicines

leukotriene-receptor-antagonists

Medicines that block leukotriene-mediated inflammatory effects.

0 linked medicines

leukotriene-receptor-antagonists

Medicines that block leukotriene-mediated inflammatory effects.

0 linked medicines

local-anesthetics

Medicines that reversibly block nerve conduction.

0 linked medicines

local-anesthetics

Medicines that reversibly block nerve conduction.

0 linked medicines

loop-diuretics

Diuretics acting in the loop of Henle.

0 linked medicines

loop-diuretics

Diuretics acting in the loop of Henle.

0 linked medicines

macrolides

Antibiotics that inhibit bacterial protein synthesis at the 50S ribosomal subunit.

0 linked medicines

macrolides

Antibiotics that inhibit bacterial protein synthesis at the 50S ribosomal subunit.

0 linked medicines

monoclonal-antibodies

Targeted biologic medicines that bind specific antigens or pathways.

1 linked medicines

monoclonal-antibodies

Targeted biologic medicines that bind specific antigens or pathways.

0 linked medicines

mood-stabilizers

Medicines used to stabilize mood, including several pharmacologically distinct agents.

0 linked medicines

mood-stabilizers

Medicines used to stabilize mood, including several pharmacologically distinct agents.

0 linked medicines

nsaids

Medicines that reduce pain, fever and inflammation, generally through cyclooxygenase inhibition.

0 linked medicines

nsaids

Medicines that reduce pain, fever and inflammation, generally through cyclooxygenase inhibition.

0 linked medicines

opioid-analgesics

Analgesics acting at opioid receptors.

0 linked medicines

opioid-analgesics

Analgesics acting at opioid receptors.

0 linked medicines

pde5-inhibitors

Medicines that inhibit PDE5 and increase cGMP signaling.

0 linked medicines

pde5-inhibitors

Medicines that inhibit PDE5 and increase cGMP signaling.

0 linked medicines

penicillins

Beta-lactam antibiotics containing a penicillin core.

0 linked medicines

penicillins

Beta-lactam antibiotics containing a penicillin core.

0 linked medicines

potassium-sparing-diuretics

Diuretics that reduce potassium loss.

0 linked medicines

potassium-sparing-diuretics

Diuretics that reduce potassium loss.

0 linked medicines

prostaglandin-analogs

Medicines that mimic or modify prostaglandin activity.

0 linked medicines

prostaglandin-analogs

Medicines that mimic or modify prostaglandin activity.

0 linked medicines

proton-pump-inhibitors

Medicines that inhibit gastric proton pumps and reduce acid secretion.

0 linked medicines

proton-pump-inhibitors

Medicines that inhibit gastric proton pumps and reduce acid secretion.

0 linked medicines

retinoids

Vitamin A-related medicines acting through retinoid pathways.

0 linked medicines

selective-serotonin-reuptake-inhibitors

Antidepressants that inhibit serotonin reuptake.

0 linked medicines

selective-serotonin-reuptake-inhibitors

Antidepressants that inhibit serotonin reuptake.

0 linked medicines

serotonin-norepinephrine-reuptake-inhibitors

Antidepressants that inhibit serotonin and norepinephrine reuptake.

0 linked medicines

serotonin-norepinephrine-reuptake-inhibitors

Antidepressants that inhibit serotonin and norepinephrine reuptake.

0 linked medicines

sglt2-inhibitors

Medicines that reduce renal glucose reabsorption.

0 linked medicines

sglt2-inhibitors

Medicines that reduce renal glucose reabsorption.

0 linked medicines

statins

Medicines that inhibit HMG-CoA reductase to lower cholesterol.

0 linked medicines

statins

Medicines that inhibit HMG-CoA reductase to lower cholesterol.

0 linked medicines

stimulants

Medicines that increase central nervous system activity.

0 linked medicines

stimulants

Medicines that increase central nervous system activity.

0 linked medicines

sulfonamide-antibiotics

Antibiotics that inhibit bacterial folate synthesis.

0 linked medicines

sulfonamide-antibiotics

Antibiotics that inhibit bacterial folate synthesis.

0 linked medicines

sulfonylureas

Medicines that stimulate pancreatic insulin release.

0 linked medicines

tetracyclines

Antibiotics that inhibit bacterial protein synthesis at the 30S ribosomal subunit.

0 linked medicines

tetracyclines

Antibiotics that inhibit bacterial protein synthesis at the 30S ribosomal subunit.

0 linked medicines

thiazide-diuretics

Diuretics commonly used in hypertension and fluid management.

0 linked medicines

thiazide-diuretics

Diuretics commonly used in hypertension and fluid management.

0 linked medicines

thiazolidinediones

Insulin-sensitizing medicines that act on PPAR-gamma.

0 linked medicines

thiazolidinediones

Insulin-sensitizing medicines that act on PPAR-gamma.

0 linked medicines

thrombin-inhibitors

Anticoagulants that directly inhibit thrombin.

0 linked medicines

thrombin-inhibitors

Anticoagulants that directly inhibit thrombin.

0 linked medicines

thyroid-hormones

Hormone replacement medicines for thyroid hormone deficiency.

0 linked medicines

thyroid-hormones

Hormone replacement medicines for thyroid hormone deficiency.

0 linked medicines

topical-antifungals

Antifungal medicines formulated for topical use.

0 linked medicines

topical-antifungals

Antifungal medicines formulated for topical use.

0 linked medicines

tricyclic-antidepressants

Antidepressants with effects on monoamine reuptake and other receptors.

0 linked medicines

tricyclic-antidepressants

Antidepressants with effects on monoamine reuptake and other receptors.

0 linked medicines

urinary-antimuscarinics

Medicines that reduce bladder smooth-muscle activity through muscarinic receptor blockade.

0 linked medicines

urinary-antimuscarinics

Medicines that reduce bladder smooth-muscle activity through muscarinic receptor blockade.

0 linked medicines

vaccines

Biological products that induce active immunity against specific diseases.

0 linked medicines

vitamin-d-analogs

Medicines that act through vitamin D pathways.

0 linked medicines

vitamin-d-analogs

Medicines that act through vitamin D pathways.

0 linked medicines

vitamin-k-antagonists

Anticoagulants that reduce vitamin K-dependent clotting factor activity.

0 linked medicines

vitamin-k-antagonists

Anticoagulants that reduce vitamin K-dependent clotting factor activity.

0 linked medicines